NCT06483217View on ClinicalTrials.gov

Optimal Injection Interval for Intra-Detrusor Botulinum Toxin

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

October 31, 2025

Conditions
Overactive BladderUrinary UrgencyUrinary IncontinenceUrge Urinary Incontinence
Interventions
BEHAVIORAL

Patient-directed follow up

Patients will be instructed to follow up for repeat injection based on bladder symptomatology at their own self-determined time interval.

Trial Locations (1)

70112

Louisiana State University Health Science Center, New Orleans

All Listed Sponsors
lead

Louisiana State University Health Sciences Center in New Orleans

OTHER

NCT06483217 - Optimal Injection Interval for Intra-Detrusor Botulinum Toxin | Biotech Hunter | Biotech Hunter